Results 81 to 90 of about 490,601 (215)

Current Advances of Molecular Biomarkers and Liquid Biopsies Techniques in Ovarian Cancer

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Ovarian cancer (OC) remains a lethal gynecological malignancy with challenges in early diagnosis, treatment monitoring, and overcoming drug resistance. Liquid biopsy, a noninvasive approach analyzing tumor‐derived components in bodily fluids, has emerged as a promising tool in OC management.
Jingxia Zhang, Weiyan Shan, Jie Yu, Huan Shi, Qiaoping Xu, Hongkai Shang   +5 more
wiley   +1 more source

Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study [PDF]

, 2016
Objectives We conducted a phase 2 trial to assess the feasibility of interval cytoreductive surgery (CS) and hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin in patients with stage III and IV pleural ovarian carcinoma in first-line ...
Roca, Lise, Goffin, Frédéric, Cordier, Lionel, Dresse, Damien, D'Hondt, Veronique, Leroy, Chantal, De Forges, Hélène, Liberale, Gabriel, Veys, Isabelle, Kerger, Joseph   +9 more
core   +1 more source

Effects of Prehabilitation by Physical Activity on Fatigue After Surgery for Colorectal Cancer. Results From Secondary Analyses in the Randomized Controlled Trial PHYSSURG‐C

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Objective The objective of this study is to explore effects on self‐reported fatigue at 4 weeks and 12 months after surgery in patients with colorectal cancer undergoing a pre‐ and postoperative exercise intervention compared to standard care in a randomized trial.
Kevin Afshari, Aron Onerup, Ying Li, Eva Angenete, Carolina Ehrencrona, Anette Wedin, Eva Haglind   +6 more
wiley   +1 more source

Prophylactic hyperthermic intraperitoneal chemotherapy can be considered in the management of advanced gastric cancer

, 2016
We read with interest the article by Dehal, Smith and Nash (1), intitled “Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review—past, present and future” and, also congratulating them for the comprehensive review performed, we ...
Saladino, Edoardo, MACRI', Antonio
core   +1 more source

Incidence and outcomes of postoperative paralytic ileus after cytoreductive surgery with HIPEC: A population‐based study

Colorectal Disease, Volume 28, Issue 8, August 2026.
Abstract Background Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is standard treatment for peritoneal metastases in Sweden. Prolonged postoperative ileus (PPOI) is a common complication following major abdominal surgery and is associated with increased morbidity and prolonged hospitalization.
Lana Ghanipour, Lana Othman Mahmmud, Biying Huang, Gabriella Jansson Palmer, Peter Cashin, Mirna Abraham‐Nordling   +5 more
wiley   +1 more source

Peritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy – A pilot study

Journal of the Egyptian National Cancer Institute, 2018
Background: Peritoneal carcinomatosis originating from colorectal cancer (PC-CRC) carries a dismal prognosis. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) have been offered to those patients with substantial
Ahmed Mostafa Mahmoud, Yahia M. Ismail, Alaadin Hussien, Yasser Debaky, Ihab S. Ahmed, Hisham S. Wahba Mikhael, Manar Moneer   +6 more
doaj   +1 more source

Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results

, 2015
Ovarian cancer (OC) is the sixth most common neoplasm in women. Hyperthermic intraperitoneal chemotherapy (HIPEC), a strategy combining maximal cytoreductive surgery with maximal regional chemotherapy, has been proposed to treat OC.
ROVIELLO, FRANCO, ROVIELLO, GIANDOMENICO, MARRELLI, DANIELE, PETRIOLI, ROBERTO   +3 more
core   +1 more source

Reasons for stopping PIPAC.

, 2023
* PIPAC = Pressurized IntraPeritoneal Aerosol Chemotherapy. CRS/HIPEC = CytoReductive Surgery/Hyperthermic IntraPeritoneal Chemotherapy.
Pierre-Louis Conan (17511346), Adeline Aime (17511349), Hugo Picchi (17511355), Solène Doat (15006081), Marc Pocard (3795094), Jade Fawaz (17511352), Brice Malgras (17511343), Anne-Cécile Ezanno (17511340)   +7 more
core   +1 more source

Adjuvant Bidirectional Chemotherapy Using an Intraperitoneal Port

Gastroenterology Research and Practice, 2012
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been established as treatment options for patients with peritoneal metastases or peritoneal mesothelioma.
Paul H. Sugarbaker, Lana Bijelic
doaj   +1 more source

Effects of bevacizumab and hyperthermia in a rodent model of hyperthermic intraperitoneal chemotherapy (HIPEC)

International Journal of Hyperthermia, 2013
Hyperthermic intraperitoneal chemotherapy (HIPEC) is more and more used in the treatment of patients with peritoneal carcinomatosis (PC) of different primary tumours. However, survival of patients with PC is still poor. The aim of this study was to evaluate the effects of preoperatively administered bevacizumab and temperature of the perfusion in an ...
openaire   +2 more sources